|
|
||||||||
|
FIGURE 3. (A) Competitive risk analysis for patients receiving 188Re and 90Y (P = 0.27). (B) Competitive risk analysis for patients with and without TBI (P = 0.12).
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |